0 antall prosjekter

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

The highly integrated INCENTIVE consortium represents true partnership between Indian and European/US groups that addresses the global health and economic challenge posed by influenza infections, to reduce the worldwide burden resulting from outbreaks. INCENTIVE’s strategic goals are to provide s...

Tildelt: kr 8,6 mill.

Prosjektperiode: 2020-2025

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

Tildelt: kr 1,1 mrd.

Prosjektperiode: 2020-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise, allowing European expansion of DisCoVeRy (WP1) and the establishment of a COVID19 adaptive ...

Tildelt: kr 11,5 mill.

Prosjektperiode: 2020-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Beyond 1M Genomes

Beyond 1M Genomes

Tildelt: kr 0,24 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Tildelt: kr 0,63 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Rapid European SARS-CoV-2 Emergency research Response

RECoVER (Rapid European SARS-CoV-2 Emergency Research response) is a comprehensive research response to the SARS-CoV-2 outbreak addressing the most urgent questions for patient and public health level interventions. RECoVER originates from partners of the EU Framework 7 (FP7) funded PREPARE proje...

Tildelt: kr 0,67 mill.

Prosjektperiode: 2020-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Prevention and Remediation of Insulin Multimorbidity in Europe

Prevention and Remediation of Insulin Multimorbidity in Europe

Tildelt: kr 3,4 mill.

Prosjektperiode: 2020-2024

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.

RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.

Tildelt: kr 18,4 mill.

Prosjektperiode: 2020-2024

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Impact of exposome on the course of lung diseases

Impact of exposome on the course of lung diseases

Tildelt: kr 3,4 mill.

Prosjektperiode: 2020-2024

Sted: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

PERsonalised MedicIne Trials

Scientific excellence, and acceptance by health authorities of results derived from research on personalised medicine require standards ensuring validity and reproducibility. The objective of PERMIT is to establish, with all relevant stakeholders and invited experts, recommendations ensuring the ...

Tildelt: Skjult

Prosjektperiode: 2020-2021

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

MULTILEVEL INTERVENTIONS TO PROMOTE MENTAL HEALTH IN SMEs AND PUBLIC WORKPLACES

MULTILEVEL INTERVENTIONS TO PROMOTE MENTAL HEALTH IN SMEs AND PUBLIC WORKPLACES

Tildelt: kr 4,3 mill.

Prosjektperiode: 2020-2023

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY

Atrial fibrillation (AF) is an increasingly common arrhythmia in the aging European population. Its prevalence will more than double by the year 2050 affecting 5% of EU women and men aged 65 years. AF carries a high risk of stroke, heart failure, and dementia, which result in a significant loss o...

Tildelt: kr 0,54 mill.

Prosjektperiode: 2020-2022

Sted: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Comorbid cardiovascular disease in people with severe mental disorders is a major public health concern and poses a considerable financial burden on European Health Care. The CoMorMent project will uncover mechanisms underlying the higher incidence of cardiovascular disease in people with mental ...

Tildelt: kr 15,0 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

Tildelt: kr 8,3 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Human Exposomic Determinants of Immune Mediated Diseases

Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors cannot explain such a rapid change. In the...

Tildelt: kr 6,3 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Chronic pain (CP) is the leading cause of disability, and is strongly associated with fatigue, anxiety and depression also major contributors to disability, and with cardiovascular disease (CVD) and mortality. Twin studies indicate that these associations are a consequence of common causal mecha...

Tildelt: kr 21,2 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Tildelt: kr 13,2 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

Tildelt: kr 20,6 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Exposome project for health and occupational research

Exposome project for health and occupational research

Tildelt: kr 9,7 mill.

Prosjektperiode: 2020-2024

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases

Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases

Tildelt: kr 4,9 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Big Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors

Head and neck cancer can take away a patient’s “right to feel human,” and its impact on physical appearance, physical functioning, psychological status and general quality of life (QoL) can be devastating. Over the past several decades, the number of patients who survive head and neck cancer (HNC...

Tildelt: kr 3,1 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Up-scaling the global univocal identification of medicines

Up-scaling the global univocal identification of medicines

Tildelt: kr 6,1 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Tildelt: kr 1,2 mill.

Prosjektperiode: 2019-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Tildelt: kr 7,3 mill.

Prosjektperiode: 2019-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Tildelt: kr 2,3 mill.

Prosjektperiode: 2019-2025

Sted: Rogaland

H20-HEALTH-Health, demographic change and wellbeing

Smart and Healthy Ageing through People Engaging in Supportive Systems

SHAPES aims to create the first European open Ecosystem enabling the large-scale deployment of a broad range of digital solutions for supporting and extending healthy and independent living for older individuals who are facing permanently or temporarily reduced functionality and capabilities. SHA...

Tildelt: kr 5,0 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

EXpanding Platforms for Efficacious mRNA Therapeutics

EXpanding Platforms for Efficacious mRNA Therapeutics

Tildelt: kr 11,1 mill.

Prosjektperiode: 2019-2025

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Tildelt: kr 2,0 mill.

Prosjektperiode: 2019-2026

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Tildelt: kr 0,30 mill.

Prosjektperiode: 2019-2022

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

EU-CEPI Framework Agreement for vaccine development

EU-CEPI Framework Agreement for vaccine development

Tildelt: Skjult

Prosjektperiode: 2019-2022

Sted: Oslo